Cases 51 - 60 of 117
Otsuka Pharmaceutical Co., Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01965
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
CHIESI USA, INC. et al v. AUROBINDO PHARMA USA, INC. et al
as 2:2019cv18756
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD.
Plaintiff:
CHIESI USA, INC. and CHIESI FARMACEUTICI S.p.A.
Cause Of Action: 35 U.S.C. § 271
CHIESI USA, INC. et al v. AUROBINDO PHARMA USA, INC. et al
as 3:2019cv18756
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD.
Plaintiff:
CHIESI USA, INC. and CHIESI FARMACEUTICI S.P.A.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01862
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
as 1:2019cv01727
Counter Defendant:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant:
MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff:
Eden Biodesign, LLC.
Defendant:
Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01674
Plaintiff:
Allergan USA, Inc., Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company and others
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al. v. Aurobindo Pharma, Ltd. et al.
as 1:2019cv00748
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialties Ltd.
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. AUROBINDO PHARMA USA INC. et al
as 3:2018cv17733
Defendant:
AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LTD.
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Cause Of Action: 35 U.S.C. § 271
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2018cv00226
Plaintiff:
Allergan USA, Inc., Allergan Sales, LLC, Forest Laboratories Holdings, LTD. and others
Defendant:
Sandoz Inc., Aurobindo Pharma, LTD., Mylan Pharmaceuticals Inc. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
